What is Direct Action?
Direct Action Co. Inc. operates at the intersection of veterinary science and consumer nutrition, providing high-performance supplements for horses, dogs, and deer. By leveraging innovative solutions such as their flagship GI-PRO3 product, the company addresses the growing demand for premium animal health interventions. Their market position is defined by a commitment to enhancing animal well-being through scientifically backed vitamins and minerals, catering to a sophisticated demographic of pet owners and livestock caretakers who prioritize efficacy and quality in their nutritional procurement.
How much funding has Direct Action raised?
Direct Action has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Direct Action
PPP
Public-Private Partnership
What's next for Direct Action?
With this late-stage capital injection, Direct Action is poised to transition from a product-focused entity to a dominant market leader in the animal health industry. Strategic priorities likely include the expansion of their distribution networks, the scaling of manufacturing capabilities to meet rising demand, and the potential for further R&D into specialized health supplements. As the company navigates this growth phase, the focus will remain on maintaining product integrity while capturing a larger share of the global pet and livestock wellness market, ensuring sustained value creation for stakeholders.
See full Direct Action company page
